{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:58:59Z","timestamp":1786982339762,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s12264-018-00336-7","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T03:24:19Z","timestamp":1547090659000},"page":"724-734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Liraglutide Ameliorates Hyperhomocysteinemia-Induced Alzheimer-Like Pathology and Memory Deficits in Rats via Multi-molecular Targeting"],"prefix":"10.1007","volume":"35","author":[{"given":"Yao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Zhao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Juan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"key":"336_CR1","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW. Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984, 120: 885\u2013890.","journal-title":"Biochem Biophys Res Commun"},{"key":"336_CR2","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 1986, 83: 4913\u20134917.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"336_CR3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/jama.1997.03540340027028","volume":"277","author":"F Lopera","year":"1997","unstructured":"Lopera F, Ardilla A, Martinez A, Madrigal L, Arango-Viana JC, Lemere CA, et al. Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. JAMA 1997, 277: 793\u2013799.","journal-title":"JAMA"},{"key":"336_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.psychres.2017.08.063","volume":"259","author":"SJ Zhou","year":"2018","unstructured":"Zhou SJ, Zhang LG, Chen HM, Li JY, Li R, Zhang XM, et al. Prevalence and clinical-demographic correlates of hyperhomocysteinemia in inpatients with bipolar disorder in a Han Chinese population. Psychiatry Res 2018, 259: 364\u2013369.","journal-title":"Psychiatry Res"},{"key":"336_CR5","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.neurobiolaging.2007.04.015","volume":"29","author":"CE Zhang","year":"2008","unstructured":"Zhang CE, Tian Q, Wei W, Peng JH, Liu GP, Zhou XW, et al. Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus. Neurobiol Aging 2008, 29: 1654\u20131665.","journal-title":"Neurobiol Aging"},{"key":"336_CR6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3233\/JAD-2011-110770","volume":"27","author":"W Wei","year":"2011","unstructured":"Wei W, Liu YH, Zhang CE, Wang Q, Wei Z, Mousseau DD, et al. Folate\/vitamin-B12 prevents chronic hyperhomocysteinemia-induced tau hyperphosphorylation and memory deficits in aged rats. J Alzheimers Dis 2011, 27: 639\u2013650.","journal-title":"J Alzheimers Dis"},{"key":"336_CR7","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2353\/ajpath.2009.081036","volume":"174","author":"CE Zhang","year":"2009","unstructured":"Zhang CE, Wei W, Liu YH, Peng JH, Tian Q, Liu GP, et al. Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. Am J Pathol 2009, 174: 1481\u20131491.","journal-title":"Am J Pathol"},{"key":"336_CR8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/jnc.12094","volume":"124","author":"GS Chai","year":"2013","unstructured":"Chai GS, Jiang X, Ni ZF, Ma ZW, Xie AJ, Cheng XS, et al. Betaine attenuates Alzheimer-like pathological changes and memory deficits induced by homocysteine. J Neurochem 2013, 124: 388\u2013396.","journal-title":"J Neurochem"},{"key":"336_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0169-328X(03)00125-6","volume":"113","author":"B Li","year":"2003","unstructured":"Li B, Xi X, Roane DS, Ryan DH, Martin RJ. Distribution of glucokinase, glucose transporter GLUT2, sulfonylurea receptor-1, glucagon-like peptide-1 receptor and neuropeptide Y messenger RNAs in rat brain by quantitative real time RT-PCR. Brain Res Mol Brain Res 2003, 113: 139\u2013142.","journal-title":"Brain Res Mol Brain Res"},{"key":"336_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0306-4522(96)00434-4","volume":"77","author":"PJ Larsen","year":"1997","unstructured":"Larsen PJ, Tang-Christensen M, Holst JJ, Orskov C. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience 1997, 77: 257\u2013270.","journal-title":"Neuroscience"},{"key":"336_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.brainres.2006.06.090","volume":"1111","author":"Y Nakade","year":"2006","unstructured":"Nakade Y, Tsukamoto K, Pappas TN, Takahashi T. Central glucagon like peptide-1 delays solid gastric emptying via central CRF and peripheral sympathetic pathway in rats. Brain Res 2006, 1111: 117\u2013121.","journal-title":"Brain Res"},{"key":"336_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.bbr.2009.06.035","volume":"205","author":"T Abbas","year":"2009","unstructured":"Abbas T, Faivre E, Holscher C. Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: interaction between type 2 diabetes and Alzheimer\u2019s disease. Behav Brain Res 2009, 205: 265\u2013271.","journal-title":"Behav Brain Res"},{"key":"336_CR13","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm919","volume":"9","author":"MJ During","year":"2003","unstructured":"During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X, et al. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med 2003, 9: 1173\u20131179.","journal-title":"Nat Med"},{"key":"336_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10571-010-9632-7","volume":"31","author":"CH Lee","year":"2011","unstructured":"Lee CH, Yoo KY, Ryu PD, Park JH, Choi JH, Kim S, et al. Decreased glucagon-like peptide-1 receptor immunoreactivity in the dentate granule cell layer from adult in the gerbil hippocampus. Cell Mol Neurobiol 2011, 31: 345\u2013350.","journal-title":"Cell Mol Neurobiol"},{"key":"336_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.2337\/diabetes.51.2.424","volume":"51","author":"CB Juhl","year":"2002","unstructured":"Juhl CB, Hollingdal M, Sturis J, Jakobsen G, Agerso H, Veldhuis J, et al. Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes. Diabetes 2002, 51: 424\u2013429.","journal-title":"Diabetes"},{"key":"336_CR16","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.2337\/diabetes.52.7.1786","volume":"52","author":"AM Chang","year":"2003","unstructured":"Chang AM, Jakobsen G, Sturis J, Smith MJ, Bloem CJ, An B, et al. The GLP-1 derivative NN2211 restores beta-cell sensitivity to glucose in type 2 diabetic patients after a single dose. Diabetes 2003, 52: 1786\u20131791.","journal-title":"Diabetes"},{"key":"336_CR17","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ejphar.2011.11.005","volume":"674","author":"L Li","year":"2012","unstructured":"Li L, Zhang ZF, Holscher C, Gao C, Jiang YH, Liu YZ. (Val(8)) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains. Eur J Pharmacol 2012, 674: 280\u2013286.","journal-title":"Eur J Pharmacol"},{"key":"336_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ejphar.2008.03.025","volume":"587","author":"VA Gault","year":"2008","unstructured":"Gault VA, Holscher C. GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid. Eur J Pharmacol 2008, 587: 112\u2013117.","journal-title":"Eur J Pharmacol"},{"issue":"Pt A","key":"336_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuropharm.2013.08.005","volume":"76","author":"PL McClean","year":"2014","unstructured":"McClean PL, Holscher C. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP\/PS1 mice, a model of Alzheimer\u2019s disease. Neuropharmacology 2014, 76 Pt A: 57\u201367.","journal-title":"Neuropharmacology"},{"key":"336_CR20","first-page":"E996","volume":"277","author":"B Ahren","year":"1999","unstructured":"Ahren B, Pacini G. Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice. Am J Physiol 1999, 277: E996\u2013E1004.","journal-title":"Am J Physiol"},{"key":"336_CR21","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nprot.2006.116","volume":"1","author":"CV Vorhees","year":"2006","unstructured":"Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 2006, 1: 848\u2013858.","journal-title":"Nat Protoc"},{"key":"336_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fnana.2016.00038","volume":"10","author":"S Zaqout","year":"2016","unstructured":"Zaqout S, Kaindl AM. Golgi-Cox staining step by step. Front Neuroanat 2016, 10: 38.","journal-title":"Front Neuroanat"},{"key":"336_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0021-9150(98)00067-7","volume":"139","author":"EJ Giltay","year":"1998","unstructured":"Giltay EJ, Hoogeveen EK, Elbers JM, Gooren LJ, Asscheman H, Stehouwer CD. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. Atherosclerosis 1998, 139: 197\u2013198.","journal-title":"Atherosclerosis"},{"key":"336_CR24","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s12264-018-0226-6","volume":"34","author":"L Luo","year":"2018","unstructured":"Luo L, Ma\u00a0J, Li Y, Hu Z, Jiang C, Cai H, et al. Cystatin C induces insulin resistance in hippocampal neurons and promotes cognitive dysfunction in rodents. Neurosci Bull 2018, 34: 543\u2013545.","journal-title":"Neurosci Bull"},{"key":"336_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol 2018, 14: 168\u2013181.","journal-title":"Nat Rev Neurol"},{"issue":"Suppl 3","key":"336_CR26","doi-asserted-by":"publisher","first-page":"S434","DOI":"10.2337\/diabetes.51.2007.S434","volume":"51","author":"PE MacDonald","year":"2002","unstructured":"MacDonald PE, El-Kholy W, Riedel MJ, Salapatek AM, Light PE, Wheeler MB. The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. Diabetes 2002, 51 Suppl 3: S434\u2013S442.","journal-title":"Diabetes"},{"key":"336_CR27","first-page":"259","volume":"44","author":"S Hoyer","year":"1994","unstructured":"Hoyer S, Muller D, Plaschke K. Desensitization of brain insulin receptor. Effect on glucose\/energy and related metabolism. J Neural Transm Suppl 1994, 44: 259\u2013268.","journal-title":"J Neural Transm Suppl"},{"key":"336_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0167-4943(95)00646-3","volume":"21","author":"N Henneberg","year":"1995","unstructured":"Henneberg N, Hoyer S. Desensitization of the neuronal insulin receptor: a new approach in the etiopathogenesis of late-onset sporadic dementia of the Alzheimer type (SDAT)? Arch Gerontol Geriatr 1995, 21: 63\u201374.","journal-title":"Arch Gerontol Geriatr"},{"key":"336_CR29","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/humrep\/deg190","volume":"18","author":"M Schachter","year":"2003","unstructured":"Schachter M, Raziel A, Friedler S, Strassburger D, Bern O, Ron-El R. Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod 2003, 18: 721\u2013727.","journal-title":"Hum Reprod"},{"key":"336_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabres.2006.07.026","volume":"76","author":"J Golbahar","year":"2007","unstructured":"Golbahar J, Aminzadeh MA, Kassab SE, Omrani GR. Hyperhomocysteinemia induces insulin resistance in male Sprague-Dawley rats. Diabetes Res Clin Pract 2007, 76: 1\u20135.","journal-title":"Diabetes Res Clin Pract"},{"key":"336_CR31","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","volume":"55","author":"KD Copps","year":"2012","unstructured":"Copps KD, White MF. Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 2012, 55: 2565\u20132582.","journal-title":"Diabetologia"},{"key":"336_CR32","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cmet.2008.04.005","volume":"7","author":"KL Hoehn","year":"2008","unstructured":"Hoehn KL, Hohnen-Behrens C, Cederberg A, Wu LE, Turner N, Yuasa T, et al. IRS1-independent defects define major nodes of insulin resistance. Cell Metab 2008, 7: 421\u2013433.","journal-title":"Cell Metab"},{"key":"336_CR33","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.jalz.2013.12.007","volume":"10","author":"K Talbot","year":"2014","unstructured":"Talbot K, Wang HY. The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer\u2019s disease. Alzheimers Dement 2014, 10: S12\u2013S25.","journal-title":"Alzheimers Dement"},{"key":"336_CR34","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, et al. Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 2012, 122: 1316\u20131338.","journal-title":"J Clin Invest"},{"key":"336_CR35","doi-asserted-by":"publisher","first-page":"9773","DOI":"10.1523\/JNEUROSCI.0354-12.2012","volume":"32","author":"HY Wang","year":"2012","unstructured":"Wang HY, Bakshi K, Frankfurt M, Stucky A, Goberdhan M, Shah SM, et al. Reducing amyloid-related Alzheimer\u2019s disease pathogenesis by a small molecule targeting filamin A. J Neurosci 2012, 32: 9773\u20139784.","journal-title":"J Neurosci"},{"key":"336_CR36","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI57256","volume":"122","author":"TR Bomfim","year":"2012","unstructured":"Bomfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel JC, Decker H, et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease- associated Abeta oligomers. J Clin Invest 2012, 122: 1339\u20131353.","journal-title":"J Clin Invest"},{"key":"336_CR37","doi-asserted-by":"publisher","first-page":"312452","DOI":"10.1155\/2014\/312452","volume":"2014","author":"W Ji","year":"2014","unstructured":"Ji W, Chen X, Lv J, Wang M, Ren S, Yuan B, et al. Liraglutide exerts antidiabetic effect via PTP1B and PI3K\/Akt2 signaling pathway in skeletal muscle of KKAy mice. Int J Endocrinol 2014, 2014: 312452.","journal-title":"Int J Endocrinol"},{"key":"336_CR38","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1523\/JNEUROSCI.3316-06.2007","volume":"27","author":"E Sontag","year":"2007","unstructured":"Sontag E, Nunbhakdi-Craig V, Sontag JM, Diaz-Arrastia R, Ogris E, Dayal S, et al. Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation. J Neurosci 2007, 27: 2751\u20132759.","journal-title":"J Neurosci"},{"key":"336_CR39","first-page":"247","volume":"9","author":"L Qi","year":"2017","unstructured":"Qi L, Chen Z, Wang Y, Liu X, Liu X, Ke L, et al. Subcutaneous liraglutide ameliorates methylglyoxal-induced Alzheimer-like tau pathology and cognitive impairment by modulating tau hyperphosphorylation and glycogen synthase kinase-3beta. Am J Transl Res 2017, 9: 247\u2013260.","journal-title":"Am J Transl Res"},{"key":"336_CR40","doi-asserted-by":"publisher","first-page":"5815","DOI":"10.1073\/pnas.081612998","volume":"98","author":"E Kojro","year":"2001","unstructured":"Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. Proc Natl Acad Sci U S A 2001, 98: 5815\u20135820.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"336_CR41","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/85064","volume":"4","author":"H Cai","year":"2001","unstructured":"Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, et al. BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci 2001, 4: 233\u2013234.","journal-title":"Nat Neurosci"},{"key":"336_CR42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuron.2005.06.030","volume":"47","author":"E McGowan","year":"2005","unstructured":"McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C, et al. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 2005, 47: 191\u2013199.","journal-title":"Neuron"},{"key":"336_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","volume":"13","author":"T Iwatsubo","year":"1994","unstructured":"Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 1994, 13: 45\u201353.","journal-title":"Neuron"},{"key":"336_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1083\/jcb.200301115","volume":"163","author":"MS Lee","year":"2003","unstructured":"Lee MS, Kao SC, Lemere CA, Xia W, Tseng HC, Zhou Y, et al. APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol 2003, 163: 83\u201395.","journal-title":"J Cell Biol"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-018-00336-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12264-018-00336-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-018-00336-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T19:18:09Z","timestamp":1578597489000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12264-018-00336-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["336"],"URL":"https:\/\/doi.org\/10.1007\/s12264-018-00336-7","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]},"assertion":[{"value":"26 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors claim that there are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}